Surrozen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Surrozen and other ETFs, options, and stocks.

About SRZN

Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K.

CEO

Craig C. Parker

CEOCraig C. Parker

Employees

Employees41

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2015

Founded2015

Employees

Employees41

SRZN Key Statistics

Market cap

85.19M

Market cap85.19M

Price-Earnings ratio

-0.47

Price-Earnings ratio-0.47

Dividend yield

—

Dividend yield—

Average volume

12.15K

Average volume12.15K

High today

$10.15

High today$10.15

Low today

$9.51

Low today$9.51

Open price

$10.15

Open price$10.15

Volume

18.07K

Volume18.07K

52 Week high

$18.17

52 Week high$18.17

52 Week low

$6.00

52 Week low$6.00

Surrozen

Why Robinhood?

Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Show more

SRZN Key Statistics

Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K.